Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Royan Cord Blood Bank, officially known as Royan Stem Cell Technology Company, is a leading biotechnology firm in Iran specializing in the collection, processing, and cryopreservation of umbilical cord blood stem cells. Established in 2005 as a subsidiary of the Royan Institute, it operates both public and private (family) cord blood banks to provide life-saving treatments for hematological and genetic disorders. The company also engages in advanced research and clinical trials exploring the use of stem cells for regenerative medicine, including treatments for neurological and cardiovascular conditions. With an extensive network of collection centers across Iran and neighboring countries, it is one of the largest cord blood banks in the Middle East. Beyond cord blood, the company has expanded its services to include the banking of peripheral blood stem cells and mesenchymal stem cells derived from various tissues.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Royan Cord Blood Bank.